Preoperative chemotherapy for T2 breast cancer is associated with improved surgical outcome

Karanlik H., Özgür I., Cabioglu N., Sen F., Erturk K., Kilic B., ...Daha Fazla

EJSO, cilt.41, sa.9, ss.1226-1233, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 41 Sayı: 9
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1016/j.ejso.2015.06.003
  • Dergi Adı: EJSO
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1226-1233
  • Anahtar Kelimeler: Preoperative chemotherapy, Breast cancer, T2 breast tumor, 20-YEAR FOLLOW-UP, CONSERVING SURGERY, NEOADJUVANT CHEMOTHERAPY, CONSERVATION THERAPY, TUMOR SIZE, AESTHETIC EVALUATION, LOCAL RECURRENCE, ADJUVANT BREAST, MARGIN STATUS, CARCINOMA
  • İstanbul Üniversitesi Adresli: Evet

Özet

Background: The aim of this study is to compare the clinical outcome in T2 breast cancer patients who underwent preoperative chemotherapy (PC) and who did not. The study also tried to define a subgroup of patients, who are more beneficial after PC in terms of lower re-excision rates, better cosmetic results and local recurrence free survival.